Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report released on Monday morning. The firm issued a sell rating on the basic materials company’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $6.00 target price on shares of Arcadia Biosciences in a research report on Wednesday, August 21st.

Arcadia Biosciences Trading Down 4.8 %

Shares of RKDA stock opened at $6.09 on Monday. The firm has a fifty day simple moving average of $3.63 and a 200-day simple moving average of $3.17. The company has a market capitalization of $8.28 million, a PE ratio of -1.42 and a beta of 1.19. Arcadia Biosciences has a twelve month low of $1.85 and a twelve month high of $10.31.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.